Literature DB >> 30335257

[Screening of frailty in family practice by the modified SEGA grid].

E Feck1, A A Zulfiqar2.   

Abstract

The objective of this study was to evaluate frailty by the use of the modified SEGA grid in a population aged 75 years and older. This cross-sectional study was carried out in Marne (Champagne Ardenne), including subjects aged 75 years or more, who can go to medical general practitioners consultation. Frailty was assessed by the modified SEGA tool. In total between May 02, 2016 and May 08, 2017, 64 patients were included, aged 80 years ± 3.87, with a majority of women (58 %). The mean frailty score was 6.3 ± 3.6, with an average time of 3 minutes 55 seconds ± 1.13. The SEGAm grid had a good discriminating capacity for age (p = 0.041), comorbidities (p = 0.016), MMS (p = 0.011), presence of home helpers (p = 2.9e-05). There was also good agreement between the obtained SEGAm score and the subjective opinion of the general practitioners with a Cohen Kappa score of 0.66. The modified SEGA grid proves to be a good tool for frailty screening for the general practitioners, allowing preventive strategies and a personalized care project to be set up for each patient.

Entities:  

Keywords:  Frailty ; Screening ; Modified SEGA grid ; General practitioners

Mesh:

Year:  2018        PMID: 30335257

Source DB:  PubMed          Journal:  Rev Med Liege        ISSN: 0370-629X


  2 in total

1.  Biomechanical response of the CNS is associated with frailty in NPH-suspected patients.

Authors:  A Vallet; N Del Campo; E O Hoogendijk; A Lokossou; O Balédent; Z Czosnyka; L Balardy; P Payoux; P Swider; S Lorthois; E Schmidt
Journal:  J Neurol       Date:  2020-01-29       Impact factor: 4.849

2.  Can sitting and lying blood pressure measurements be considered interchangeable in older frail adults?

Authors:  Sara Gabriele; Ioannis Georgiopoulos; Carlos Labat; Marina Kotsani; Sylvie Gautier; Francesco Fantin; Athanase Benetos
Journal:  Eur Geriatr Med       Date:  2022-09-02       Impact factor: 3.269

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.